Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

ANJU VASUDEVAN

Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology

NPI
1043203888
CMS profile
1601
Location
OCALA, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2021 · Entire year

$8,641.90

207 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2021 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $3,497.85 199
Honoraria $2,730.00 2
Consulting Fee $2,363.50 2
Education $50.55 4

By paying entity

PY2021 · entire year · sorted by reported total

Paying entityAmountRecords
Janssen Biotech, Inc. $1,618.73 10
G1 Therapeutics, Inc. $1,500.00 1
Blueprint Medicines Corporation $1,272.57 4
Celgene Corporation $980.03 9
AstraZeneca Pharmaceuticals LP $345.98 17
Amgen Inc. $244.85 14
Seagen Inc. $187.00 12
E.R. Squibb & Sons, L.L.C. $158.98 9
Bayer HealthCare Pharmaceuticals Inc. $145.00 6
GlaxoSmithKline, LLC. $144.53 8
Daiichi Sankyo Inc. $140.02 9
Merck Sharp & Dohme Corporation $119.77 6
Incyte Corporation $119.54 7
Genentech USA, Inc. $102.30 6
Pharmacyclics LLC, An AbbVie Company $99.64 7
TG THERAPEUTICS, INC. $88.58 2
GENZYME CORPORATION $86.09 5
JAZZ PHARMACEUTICALS INC. $81.44 4
Heron Therapeutics, Inc. $73.11 4
BeiGene USA, Inc. $70.70 3
PUMA BIOTECHNOLOGY, INC. $70.29 4
Astellas Pharma US Inc $64.54 5
Kite Pharma, Inc. $62.87 4
PFIZER INC. $61.63 4
Rigel Pharmaceuticals, Inc. $60.78 2
Eisai Inc. $60.13 4
Global Blood Therapeutics, Inc. $59.29 4
Lilly USA, LLC $59.08 4
MorphoSys, US Inc. $59.05 2
Takeda Pharmaceuticals U.S.A., Inc. $53.85 3
Servier Pharmaceuticals LLC $53.40 3
Novartis Pharmaceuticals Corporation $52.46 3
Boehringer Ingelheim Pharmaceuticals, Inc. $46.48 2
Kyowa Kirin, Inc. $32.59 2
ARRAY BIOPHARMA INC $30.31 2
Dova Pharmaceuticals $30.19 2
CSL Behring $28.11 2
AbbVie Inc. $26.13 2
EUSA Pharma (US) LLC $21.21 1
Alexion Pharmaceuticals, Inc. $18.61 1
Foundation Medicine, Inc. $18.55 1
Exelixis Inc. $16.29 1
Deciphera Pharmaceuticals Inc. $14.24 1
Aveo Pharmaceuticals, Inc. $14.14 1
Epizyme, Inc., $13.53 1
Karyopharm Therapeutics Inc. $13.01 1
Gilead Sciences, Inc. $11.92 1
GE HEALTHCARE $10.36 1

Page 3 of 5; records 101–150 of 207 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

ANJU VASUDEVAN

NPI 1043203888 · CMS profile ID 1601

Allopathic & Osteopathic Physicians / Internal Medicine / Medical Oncology

OCALA, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 3 of 5; records 101–150 of 207 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1043203888?year=2021&recipient=provider&page=3#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
ANJU VASUDEVAN, NPI 1043203888, CMS profile ID 1601. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 5; records 101–150 of 207 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1043203888?year=2021&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
APA 7
IndustryPayments. (2026). ANJU VASUDEVAN, NPI 1043203888, CMS profile ID 1601. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 5; records 101–150 of 207 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1043203888?year=2021&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
Bluebook
ANJU VASUDEVAN, NPI 1043203888, CMS profile ID 1601, IndustryPayments, General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 3 of 5; records 101–150 of 207 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202. https://industrypayments.org/provider/npi-1043203888?year=2021&recipient=provider&page=3#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2021 · Physicians and non-physician practitioners · CMS publication 2026-06-30

207 matching records · $8,641.90 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 207 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 101–150 of 207.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Kite Pharma, Inc. $13.6108/03/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 844423115 CMS
Daiichi Sankyo Inc. $17.5707/30/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 836309509 CMS
G1 Therapeutics, Inc. $1,500.0007/30/2021 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 840102649 CMS
Amgen Inc. $14.7907/28/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 825147103 CMS
GENZYME CORPORATION $17.7207/26/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 843458381 CMS
Daiichi Sankyo Inc. $25.4807/23/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 836308045 CMS
Celgene Corporation $885.0007/22/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 783726159 CMS
JAZZ PHARMACEUTICALS INC. $23.2307/21/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 845551927 CMS
E.R. Squibb & Sons, L.L.C. $17.5807/16/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 783635295 CMS
E.R. Squibb & Sons, L.L.C. $18.2207/14/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 783635297 CMS
PFIZER INC. $14.1107/13/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 832614087 CMS
Pharmacyclics LLC, An AbbVie Company $11.3307/10/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 781015885 CMS
Pharmacyclics LLC, An AbbVie Company $12.1107/06/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 781015883 CMS
Novartis Pharmaceuticals Corporation $18.1007/02/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 813336199 CMS
AstraZeneca Pharmaceuticals LP $13.9606/30/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829592305 CMS
Merck Sharp & Dohme Corporation $15.1606/24/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848649913 CMS
Amgen Inc. $24.0606/23/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 826294925 CMS
PFIZER INC. $13.3006/23/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 832572333 CMS
GlaxoSmithKline, LLC. $14.2006/21/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 803195621 CMS
Janssen Biotech, Inc. $19.3506/18/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 788961665 CMS
Genentech USA, Inc. $12.2406/16/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 835888889 CMS
AbbVie Inc. $11.9906/15/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 796199141 CMS
Janssen Biotech, Inc. $19.2806/15/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 788961667 CMS
Takeda Pharmaceuticals U.S.A., Inc. $19.9106/11/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 820317209 CMS
Seagen Inc. $16.0806/10/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 832160785 CMS
EUSA Pharma (US) LLC $21.2106/08/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 852884495 CMS
Pharmacyclics LLC, An AbbVie Company $11.0906/08/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 781015881 CMS
Gilead Sciences, Inc. $11.9206/01/2021 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 845880461 CMS
GlaxoSmithKline, LLC. $6.1105/31/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 802323729 CMS
AstraZeneca Pharmaceuticals LP $18.0405/28/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 830018855 CMS
Blueprint Medicines Corporation $1,230.0005/28/2021 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848929345 CMS
Deciphera Pharmaceuticals Inc. $14.2405/28/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 826798281 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $24.1505/26/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 763469304 CMS
Merck Sharp & Dohme Corporation $19.2605/25/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848603941 CMS
Celgene Corporation $16.4605/24/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 783726107 CMS
Heron Therapeutics, Inc. $40.1005/21/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 781449915 CMS
Incyte Corporation $16.5805/21/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 835522443 CMS
E.R. Squibb & Sons, L.L.C. $21.6205/19/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 783635281 CMS
Servier Pharmaceuticals LLC $20.2605/17/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 852925065 CMS
Celgene Corporation $12.2405/14/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 783726113 CMS
Janssen Biotech, Inc. $8.9105/13/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 788961657 CMS
Amgen Inc. $13.4905/11/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 826294921 CMS
BeiGene USA, Inc. $39.4705/11/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 846696087 CMS
Exelixis Inc. $16.2905/11/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 838868967 CMS
Genentech USA, Inc. $18.7005/06/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 835888891 CMS
MorphoSys, US Inc. $17.5705/04/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 854731895 CMS
Daiichi Sankyo Inc. $31.5005/03/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 836293369 CMS
AstraZeneca Pharmaceuticals LP $15.1005/01/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829757645 CMS
GlaxoSmithKline, LLC. $24.9604/29/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 802564729 CMS
Kite Pharma, Inc. $14.4004/26/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 844423123 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $7,334.59 196
PY2020 $11,730.82 169
PY2021 $8,641.90 207
PY2022 $11,709.39 234
PY2023 $8,827.27 216
PY2024 $5,563.29 224
PY2025 $10,729.10 186

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $615,355.98 6
PY2024 Principal investigator $65,007.80 9
PY2023 Principal investigator $101,468.00 33
PY2022 Principal investigator $71,026.00 44
PY2021 Principal investigator $9,181.40 5
PY2020 Recipient $139.20 1
PY2020 Principal investigator $24,956.00 4
PY2019 Recipient $1,925.67 2
PY2019 Principal investigator $36,438.65 24

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

6 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Novartis Pharmaceuticals Corporation $80.86 11/04/2025 Non-covered Recipient Entity
THE ONCOLOGY RESEARCH INSTITUTE LLC
A Phase IIIb Study to Characterize the Effectiveness and Safety of Adjuvant Ribociclib in a Wide Patient Population With HR+ HER2- Early Breast Cancer (Adjuvant WIDER) No dispute reported 06/30/2026 1190312333
Principal investigator 1 Novartis Pharmaceuticals Corporation $121,062.48 09/04/2025 Non-covered Recipient Entity
THE ONCOLOGY RESEARCH INSTITUTE LLC
A Phase IIIb Study to Characterize the Effectiveness and Safety of Adjuvant Ribociclib in a Wide Patient Population With HR+ HER2- Early Breast Cancer (Adjuvant WIDER) No dispute reported 06/30/2026 1190312335
Principal investigator 1 ABBVIE INC. $40,884.36 05/14/2025 Non-covered Recipient Entity
OCALA ONCOLOGY CENTER PL
A Phase 3 Multicenter Randomized Open-Label Trial to Evaluate Safety and Efficacy of Epcoritamab in Combination with R-CHOP compared to R-CHOP in Subjects with High-Risk Diffuse Large B-Cell Lymphoma No dispute reported 06/30/2026 1202484835
Principal investigator 1 ABBVIE INC. $9,045.00 05/13/2025 Non-covered Recipient Entity
OCALA ONCOLOGY CENTER PL
A Phase 3 Multicenter Randomized Open-Label Trial to Evaluate Safety and Efficacy of Epcoritamab in Combination with R-CHOP compared to R-CHOP in Subjects with High-Risk Diffuse Large B-Cell Lymphoma No dispute reported 06/30/2026 1202484735
Principal investigator 1 ABBVIE INC. $5,000.00 05/07/2025 Non-covered Recipient Entity
OCALA ONCOLOGY CENTER PL
A Phase 3 Multicenter Randomized Open-Label Trial to Evaluate Safety and Efficacy of Epcoritamab in Combination with R-CHOP compared to R-CHOP in Subjects with High-Risk Diffuse Large B-Cell Lymphoma No dispute reported 06/30/2026 1202483379
Principal investigator 1 Novartis Pharmaceuticals Corporation $439,283.28 04/16/2025 Non-covered Recipient Entity
THE ONCOLOGY RESEARCH INSTITUTE LLC
A Phase IIIb Study to Characterize the Effectiveness and Safety of Adjuvant Ribociclib in a Wide Patient Population With HR+ HER2- Early Breast Cancer (Adjuvant WIDER) No dispute reported 06/30/2026 1190312337

Ownership and Investment Interests

One row per program year and measure, newest year first · the amount invested and the value of the interest are never added together

Program yearMeasureAmountRecords
PY2022 Amount invested $0.00 1
PY2022 Value of interest $119,000.00 1
PY2021 Amount invested $0.00 1
PY2021 Value of interest $92,200.00 1
PY2020 Amount invested $0.00 1
PY2020 Value of interest $90,000.00 1
PY2019 Amount invested $0.00 1
PY2019 Value of interest $135,000.00 1

Ownership and Investment Interests are a separate CMS dataset, shown here separately and never added to payments.

Ownership and investment interests are reported as the value of an interest held, not as a payment received. They are a different measure from the payment total on this page and are never combined with it.

Ownership and Investment Interests records

Ordering applied by this site (program year, newest first, then company) · record values are shown as CMS published them

4 records · PY2019–2022

Ownership and Investment Interests records (CSV)

Program yearCompanyAmount invested Value of interestTerms of interestInterest held by Dispute statusPublishedRecord ID
PY2022 Innovation Technologies Inc $0.00 $119,000.00 Common Shares Physician Covered Recipient No dispute reported 06/30/2026 954225435
PY2021 Innovation Technologies Inc $0.00 $92,200.00 Common Shares Physician Covered Recipient No dispute reported 06/30/2026 849647691
PY2020 Innovation Technologies Inc $0.00 $90,000.00 Common Shares Physician Covered Recipient No dispute reported 06/30/2026 749849307
PY2019 Innovation Technologies Inc $0.00 $135,000.00 Common Shares Physician Covered Recipient No dispute reported 06/30/2026 694466579